Try our beta test site
13352 studies found for:    Encephalopathy
Show Display Options
Rank Status Study
21 Unknown  Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hypertension, Portal;   Liver Cirrhosis
Interventions: Drug: Erythromycin;   Drug: Neomycin
22 Recruiting Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin
23 Recruiting Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy
Condition: Hypoxic-ischemic Encephalopathy
Intervention: Device: hyperbaric oxygen
24 Completed Rifaximin in Minimal Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: placebo
25 Completed Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
26 Recruiting Magnetic Resonance Biomarkers in Neonatal Encephalopathy
Condition: Neonatal Encephalopathy
Intervention:
27 Not yet recruiting High Protein Diet Versus Normal Protein Diet in Treating Patients With Minimal Hepatic Encephalopathy
Condition: Liver Cirrhosis
Interventions: Dietary Supplement: High protein diet;   Dietary Supplement: Normal protein
28 Completed Hypothermia for Encephalopathy in Low Income Countries-Feasibilty
Condition: Neonatal Encephalopathy
Intervention: Device: Tecotherm-HELIX
29 Terminated
Has Results
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
30 Unknown  Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy
Condition: Sepsis
Intervention: Other: no interventions
31 Unknown  The Effects of Nitazoxanide in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Nitazoxanide;   Drug: Oral lactulose;   Drug: Metronidazole;   Drug: Rifaximine
32 Completed Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
Conditions: Minimal Hepatic Encephalopathy;   Hepatic Encephalopathy
Intervention: Drug: Lactulose
33 Completed A Retrospective Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) (The RETRO Study)
Condition: Hepatic Encephalopathy
Intervention:
34 Recruiting Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
Condition: Posterior Reversible Encephalopathy Syndrome
Intervention:
35 Completed Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
Conditions: Liver Cirrhosis;   Hepatic Encephalopathy
Interventions: Drug: Lactulose and rifaximin;   Dietary Supplement: Branched Chain amino acids;   Other: Placebo
36 Completed Cord Blood for Neonatal Hypoxic-ischemic Encephalopathy
Condition: Neonatal Hypoxic Ischemic Encephalopathy
Interventions: Biological: infusion of autologous cord blood;   Other: Neurodevelopmental outcomes
37 Completed Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
Conditions: Hepatic Encephalopathy;   Minimal Hepatic Encephalopathy;   Cirrhosis
Interventions: Procedure: Vastus Muscle Biopsy;   Drug: LOLA or placebo;   Other: Cognitive assessment (PHES);   Other: Cognitive Assessement (Cogstate);   Other: blood and urine sampling;   Other: Nutritional assessment;   Other: MRI brain and spectroscopy;   Other: MRI leg cross section;   Other: Functional MRI (working memory and attention tasks)
38 Suspended Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Dietary Supplement: Lactose-free milk;   Dietary Supplement: Whole milk
39 Recruiting Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
Condition: Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions: Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
40 Completed Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: L-Ornithine L-Aspartate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.